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Obesity has reached global epidemic proportions and creating an urgent need to understand mecha-
nisms underlying excessive and uncontrolled food intake. Ghrelin, the only known circulating orexigenic
hormone, potently increases food reward behavior. The neurochemical circuitry that links ghrelin to the
mesolimbic reward system and to the increased food reward behavior remains unclear.
Here we examine whether VTA-NAc dopaminergic signaling is required for the effects of ghrelin on
food reward and intake. In addition, we examine the possibility of endogenous ghrelin acting on the VTA-
NAc dopamine neurons. A D1-like or a D2 receptor antagonist was injected into the NAc in combination
with ghrelin microinjection into the VTA to investigate whether this blockade attenuates ghrelin-induced
food reward behavior. VTA injections of ghrelin produced a signiﬁcant increase in food motivation/
reward behavior, as measured by sucrose-induced progressive ratio operant conditioning, and chow
intake. Pretreatment with either a D1-like or D2 receptor antagonist into the NAc, completely blocked the
reward effect of ghrelin, leaving chow intake intact. We also found that this circuit is potentially relevant
for the effects of endogenously released ghrelin as both antagonists reduced fasting (a state of high
circulating levels of ghrelin) elevated sucrose-motivated behavior but not chow hyperphagia.
Taken together our data identify the VTA to NAc dopaminergic projections, along with D1-like and
D2 receptors in the NAc, as essential elements of the ghrelin responsive circuits controlling food reward
behavior. Interestingly results also suggest that food reward behavior and simple intake of chow are
controlled by divergent circuitry, where NAc dopamine plays an important role in food reward but not in
food intake.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license. 1. Introduction
The circulating hormone ghrelin and the neural circuits through
which it operates are well researched in the context of obesity and
appetite control (Skibicka and Dickson, 2011), motivated also by
therapeutic opportunities in this disease area (Cardona Cano et al.,gy, Institute of Neuroscience
University of Gothenburg,
rg, Sweden. Tel.: þ46 31 786
P. Skibicka).
r Ltd. Open access under CC BY-NC-ND2012). Ghrelin is unique amongst the circulating gut peptides in that
it increases food intake (Wren et al., 2000; Inui, 2001; Shintani et al.,
2001; Kojima and Kangawa, 2002) a CNS effect mediated by dedi-
cated receptors, GHS-R1A (Salome et al., 2009; Skibicka et al., 2011)
notably those located in brain areas involved in “homeostatic
feeding” (i.e. feeding linked to energy deﬁcit), the hypothalamus
and brainstem (Melis et al., 2002; Faulconbridge et al., 2003;
Olszewski et al., 2003). Recently, however, a role for ghrelin
outside of these homeostatic regions has emerged. GHS-R1A is also
present in key nodes of the mesolimbic reward system, in areas
such as the ventral tegmental area (VTA) and the nucleus accum-
bens (NAc) (Zigman et al., 2006; Skibicka et al., 2011), areas involved
in incentive motivated behavior that have also been linked to “he-
donic feeding” (i.e. food intake coupled to its rewarding properties).
Ghrelin is able to drive food intake from both of these sites and this license. 
Fig. 1. Diagrams representing different experimental designs utilized. Schedule 1 was
used to obtain data presented in Figs. 3 and 4. Schedule 2 was used to obtain data
presented in Fig. 5 and schedule 3 for data displayed in Figs. 6 and 7. The solid gray
boxes represent periods when measurements were collected.
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motivational reward value of foods (Naleid et al., 2005; Abizaid
et al., 2006; Skibicka et al., 2011). Thus, in fully satiated rats or
mice, ghrelin applied peripherally or centrally (including directly
into the VTA) leads to an increased food intake and also food reward
behavior (Naleid et al., 2005; Perello et al., 2010; Skibicka et al., 2011,
2012b) reﬂected, for example, by increased lever-pressing for a
sugar reward in a progressive ratio operant schedule. This action
reﬂects an emerging role for ghrelin within the mesolimbic reward
system to enhance reward behavior, not only for food but also for
alcohol and drugs of abuse (Dickson et al., 2011). Importantly, this
effect of ghrelin on food motivation over-rides satiety signals, as
ghrelin elicits food reward behavior in satiated animals to a level
comparable to that detected in food-deprived rats. Furthermore, the
fact that blockade of the ghrelin signal, not only systemically but
also selectively within the VTA (Skibicka et al., 2011), results in a
potent suppression of food reward behavior underscores the
importance and necessity of the ghrelin signal in food reward.
Ghrelin action at the level of the VTA is sufﬁcient to drive food
intake and motivated behavior, effects that appear to require
signaling via GHS-R1A (Abizaid et al., 2006; Skibicka et al., 2011).
Surprisingly, the circuitry downstream of ghrelin’s reward-
promoting actions in the VTA remains largely unresolved. Within
the VTA, ghrelin engages opioid, NPY and GABAergic signaling
(Abizaid et al., 2006; Skibicka et al., 2012a). Nonetheless, VTA
dopamine neurons, shown previously to express ghrelin receptors
(Abizaid et al., 2006),may be the ﬁnal VTA target for ghrelin’s effects
on food reward. Palatable/rewarding foods engage the VTA dopa-
mine neurons and the dopamine signal in select CNS areas such as
the NAc, thereby stimulating food reward behavior (Hernandez and
Hoebel, 1988; Joseph and Hodges, 1990). It should be noted, how-
ever, that although dopamine release has been strongly linked to
motivated behavior for food, it is also necessary for basic feeding as
mice which are unable to synthesize dopamine die of starvation
(Cannon et al., 2004). A functional link between ghrelin and dopa-
mine is suggested by the effects of ghrelin on VTA dopamine neuron
activity and also by the fact that intact VTA dopaminergic neurons
are needed for ghrelin’s effects on food reward (Abizaid et al., 2006;
Weinberg et al., 2011). However, the VTA dopamine neurons project
to a number of sites and it remains completely unexplored whether
dopamine signaling in the NAc is required for VTA-driven effects of
ghrelin on food-motivated behavior. Furthermore, ghrelin is
involved in the control of behaviors other than food intake or
motivation, namely novelty-seeking, which have also been linked to
dopamine release in theNAc (Bardoet al.,1996;Hanssonet al., 2012).
In the present study, we tested the hypothesis that the effects of
ghrelin on food motivated behavior and/or food intake exerted at
the level of the VTA require dopamine receptor signaling in the NAc.
To this end, food intake and food motivated behavior induced by
VTA ghrelin was assessed in the progressive ratio lever-pressing for
sucrose paradigm alongwith simultaneous NAc dopamine signaling
blockade. In separate studies we tested the individual contribution
of dopamine 1 (D1) like receptors and dopamine 2 receptors (D2).
Furthermore, in order to explore the contribution of endogenous
ghrelin to the NAc dopamine signal, we determined whether these
dopamine receptors play a role in hunger-driven enhancement of
food reward behavior. Finally, in order to evaluate the molecular
consequences of endogenously elevated ghrelin in NAc dopamine
signaling, we determined the effect of hunger/food deprivation on
mRNA expression of NAc dopamine receptors and enzymes.
2. Materials and methods
Animals: Adult male Sprague-Dawley rats (200e250 g, Charles River, Germany)
were housed in a 12-h light/dark cycle (lights on at 6 am) with regular chow and
water available ad libitum in their home cages. All animal procedures were carriedout with ethical permission and in accordance with the University of Gothenburg
Institutional Animal Care and Use Committee guidelines.
Surgery: All rats in the behavioral studies were implanted with a guide cannula
(26 gauge; Plastics One, Roanoke, VA), targeting the VTA and the NAc shell for
subsequent unilateral, ipsilateral injections. Ketamine anesthesia was used.
Cannulae were placed 1.5 mm above the target site, and an injector extending
1.5 mm from guide cannulae was used for microinjections. To target the VTA, the
following coordinates were chosen from Skibicka et al. (2011): 0.75 from the
midline, 5.7 mm posterior to bregma, and 6.5 mm ventral from the surface of the
skull, with injector aimed 8.0 mm ventral to skull. For the NAc shell, the following
coordinates were used (modiﬁed from Quarta et al. (2009): 0.75 from the midline,
1.7 mm anterior to bregma, and 6.0 mm ventral to skull, with injector aimed 7.5 mm
ventral). Cannulae were attached to the skull with dental acrylic cement and jew-
eler’s screws and closed with an obturator, as described previously (Skibicka et al.,
2009). In all rats, the microinjection site for both VTA and NAc was veriﬁed post
mortem, by microinjection of india-ink at the same microinjection volume (0.5 ml)
used throughout the study. Only subjects with the correct placement (Fig. 2) were
included in the data analysis.
2.1. Operant conditioning procedure
Operant conditioning experiments took place in rat operant conditioning
chambers (30.5  24.1  21.0 cm; Med-Associates, Georgia, VT, USA). The training
procedure used for operant conditioning was adapted from previous studies (la
Fleur et al., 2007; Hansson et al., 2012). To facilitate operant training for sucrose,
all rats were subjected to a mild food restriction during which their initial body
weight was gradually reduced to 90% over a period of one week. Prior to placement
in the operant boxes, rats were exposed to the sucrose pellets (45 mg sucrose pel-
lets; test Diet, Richmond, IN, USA) in the home cage environment on at least two
occasions. Next, rats learned to lever press for sucrose pellets under a ﬁxed ratio FR1
schedule, with 2 sessions/day. In FR1, a single press on the active lever resulted in the
delivery of one sucrose pellet. All FR sessions lasted 30 min or until the rats earned
50 pellets, whichever occurred ﬁrst. Most rats achieved the 50 pellets per session
criterion after 5e7 days. Presses on the inactive lever were recorded, but had no
programmed consequence. FR1 schedule sessions were followed by FR3 and FR5 (i.e.
3 and 5 presses per pellet respectively). The FR5 schedule was followed by the
progressive ratio (PR) schedule during which the cost of a reward was progressively
increased for each following reward, in order to determine the amount of work the
rat is willing to put into obtaining the reward. The response requirement increased
according to the following equation: response ratio¼(5e(0.2  infusion number)) e
Fig. 2. Representative NAc (A) and VTA (B) injection site (indicated by the circle). Right
panel represents the coronal rat brain section with india-ink microinjected into the
VTA or NAc shell (NAcS) at the 0.5 ml volume used in the study. The left panel shows a
corresponding rat brain atlas section, 2.16 mm anterior to bregma for the NAc and 5.64
posterior to bregma for the VTA; Aq, aquaduct; cc, corpus collosum; CPu, caudate and
putamen; LV, lateral ventricle; NAcC, NAc core; SN, substantia nigra.
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178, 219, 268, 328. The PR session ended when the rat had failed to earn a reward
within 60 min. Responding was considered stable when the number of food pellets
earned per session did not differ more than 15% for three consecutive sessions. In
most cases, responding stabilized within 5 sessions. Those rats that did not reach the
required criteria in that amount of time were trained in additional sessions. The PR
test was carried out on 1 session/day. Rats were subsequently transferred to their
home cages for 1 h chow intake measurement. At the end of training and prior to
surgery and testing, rats had ad libitum access to normal chow.
2.2. Drugs
Acylated rat ghrelin (Tocris, Bristol, UK) was administered to the VTA at a dose of
1.0 mg with artiﬁcial cerebrospinal ﬂuid (aCSF) as vehicle (and control). The 1.0 mg
dose of ghrelin has previously been shown to increase operant responding for sugar
and to induce an orexigenic responsewhen delivered to the VTA (Naleid et al., 2005;
Skibicka et al., 2011). The D1-like receptor antagonist, SCH-23390, was administered
to the NAc at a dose of 0.3 mg (Tocris), with aCSF as vehicle (control). For the food
deprivation study, the dose was increased to 0.5 mg due to lack of effect of the
original 0.3 mg dose. SCH-23390 is a potent and selective antagonist of D1-like
dopamine receptors with >1000-fold afﬁnity for D1-like versus D2-like dopamine
receptors (Barnett et al., 1986). It has a similar afﬁnity for D1 and D5 receptors
(Barnett et al., 1992) hence throughout the study we will refer to its ability to block
D1-like receptors, a term encompassing both D1 and D5 receptors. The initial 0.3 mg
dose of SCH-23390was chosen based on (Grimm et al., 2011). This dose injected into
the shell of NAc was shown to be effective at reducing lever pressing for a cue
previously paired to the delivery of a sucrose solutionwithout affecting performance
at the inactive lever. The dopamine D2 receptor antagonist, eticlopride hydrochlo-
ride (Tocris), was administered to the NAc with aCSF as vehicle (control). The initial
dose of eticlopride chosen (1.0 mg) was based on (Laviolette et al., 2008) but was
increased to 1.5 mg in the food deprivation study. All drugs were delivered in a 0.5 ml
volume of aCSF.2.3. Experimental design
All rats received NAc and VTA directed injections early in the light cycle, with the
second injection at 10 min prior to the start of operant testing. All conditions were
separated byaminimumof 48 h and run in a counterbalancedmanner, such that each
rat received all four conditions: ﬁrst vehicle or dopamine receptor antagonist to the
NAc and then, 10 min later, vehicle or ghrelin to the VTA. For each rat the ipsilateral
VTA and NAc were targeted. Details of each experiment are also illustrated in Fig. 1.
2.3.1. Effect of D1-like receptor blockade on ghrelin-induced food reward and chow
intake
Responses were examined after targeted VTA and NAc (n¼ 12e14) drug delivery
after four conditions as follows: 1) control condition (vehicle solutions to the NAc
and VTA), 2) NAc vehicle þ VTA 1.0 mg ghrelin, 3) NAc 0.3 mg SCH-23390 þ VTA
vehicle, 4) NAc 0.3 mg SCH-23390þ VTA 1.0 mg ghrelin. Testing was performed in the
satiated state (after the dark cycle period of feeding). On experimental days rats
were returned to their home cages after 120 min of operant testing and chow intake
was measured during 1 h in the home cage environment (as in schedule 1, Fig. 1).
This time point corresponds to the third hour after VTA ghrelin injection, during
which an orexigenic response would be expected to continue, based on previous
studies exploring the time course of action of ghrelin, administered centrally or
peripherally (Wren et al., 2000; Faulconbridge et al., 2003) and our previous studies
that utilized a similar experimental setup.
2.3.2. Effect of D2 receptor blockade on ghrelin-induced food reward and chow
intake
Responses were examined after targeted VTA and NAc (n ¼ 7) drug delivery in
four conditions as follows:1) control condition (vehicle solutions to theNAcandVTA),
2) NAc vehicle þ VTA 1.0 mg ghrelin, 3) NAc 1 mg eticlopride hydrochloride þ VTA
vehicle, 4) NAc 1 mg eticlopride hydrochloride þ VTA 1.0 mg ghrelin. Testing was
performed in the satiated state (after the dark cycle period of feeding). Rats were
returned to their home cages after 120 min of operant testing and chow intake was
measured during 1 h in the home cage environment (as in schedule 1, Fig. 1) as
ghrelin-mediated orexigenic effect is still present after a delayed placement of chow
pellets (after 2 h).
2.3.3. Effects of D1-like and D2 receptor blockade (separate or combined) on
ghrelin-induced chow intake alone
In order to conﬁrm that the results obtained on chow intake in the previous
experiments were not confounded by the prior exposure to the sucrose in the op-
erant paradigm or the 2 h time delay, in a separate study, we explored the effects of
NAc delivery of the two dopamine receptor antagonists alone or in combination on
VTA ghrelin-induced 2 and 3 h food intake in satiated rats (n¼ 10e11; as in schedule
2, Fig.1). In this case the rats were not exposed to the operant conditioning paradigm
prior to chowmeasurement. Thus, food intake was measured after targeted VTA and
NAc drug delivery after four conditions as follows: 1) control condition (vehicle so-
lutions to the NAc and VTA), 2) NAc vehicle þ VTA 1.0 mg ghrelin, 3) NAc dopamine
receptor antagonistþVTAvehicle, 4) NAcdopamine receptor antagonistþVTA 1.0 mg
ghrelin. First we explored the two dopamine receptor antagonists separately such
that, in conditions 3 and 4, one group of rats received 0.3 mg SCH-23390 and the other
group received 1 mg eticlopride hydrochloride. After recovery for 3 days, approxi-
mately half of the rats from each group were retested, this time with a combination
of the two antagonists in conditions 3 and 4. In each of these 3 experiments a
counterbalanced designwas used between treatments, as before (all rats received all
conditions in each experiment for within subject comparison of effect). The position
of the cannulae was veriﬁed post-mortem as before. Data shown include only rats
with injection placement conﬁrmed to reach the VTA and NAc.
2.3.4. Effect of D1-like and D2 receptor blockade on food deprivation-induced food
reward and chow intake
The dopamine receptor antagonists were tested in 2 different experiments. In
the ﬁrst experiment, responses were examined after targeted NAc (n ¼ 20) delivery
of either vehicle or the D1-like receptor antagonist (0.5 mg SCH-23390). Testing was
performed in the fasted state (after food has been restricted for the duration of the
dark cycle period). In the second experiment responses were examined after tar-
geted NAc (n ¼ 7) delivery of either vehicle or 1.5 mg NAc eticlopride hydrochloride.
Testing was performed in the fasted state (after food has been restricted for the
duration of the dark cycle period; as illustrated in schedule 3, Fig. 1).
2.3.5. Food deprivation-induced changes in dopamine related gene expression in
NAc
Food deprivation-driven changes in gene expression of key selected dopamine-
related genes [dopamine receptors D1A, D2, D3, D5, catechol-O-methyltransferase
(COMT), and monoamine oxidase A (MAO)] were measured in the NAc.
2.3.6. RNA isolation and mRNA expression
Brains were rapidly removed and the NAc was dissected using a brain matrice,
frozen in liquid nitrogen and stored at 80 C for later determination of mRNA
expression. Individual brain samples were homogenized in Qiazol (Qiagen, Hilden,
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Lipid Tissue Mini Kit (Qiagen) with additional DNAse treatment (Qiagen). RNA
quality and quantity were assessed by spectrophotometric measurements (Nano-
drop 1000, NanoDrop Technologies, USA). For cDNA synthesis iScript cDNA Syn-
thesis kit (BioRad) was used. Real-time RT PCR was performed using TaqMan
probe and primer sets for target genes chosen from an on-line catalog (Applied
Biosystems). Gene expression values were calculated based on the Ct method (Livak
and Schmittgen, 2001), where the ad libitum fed group was designated the cali-
brator. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as refer-
ence gene.
2.3.7. Statistical analysis
All behavioral parameters were analyzed by repeated measures analysis of
variance (ANOVA) followed by post hoc Tukey HSD test as appropriate or student’s t
test where only two conditions were compared. All statistical analyses were con-
ducted using the GraphPad software. Differences were considered signiﬁcant at
p < 0.05.
3. Results
3.1. Effect of D1-like receptor blockade (NAc) on VTA ghrelin-
induced food reward and chow intake
To determine whether activity at the D1-like receptors is neces-
sary for the VTA ghrelin-induced increase in food reward behavior
the impact of pretreatment with a D1-like antagonist (SCH-23390)
on ghrelin-induced operant responding for sucrose was tested. A
post hoc Tukey test following a one way ANOVA (F(3,33) ¼ 11.1,
p < 0.0005; F(3,33) ¼ 3.7, p < 0.01; F(3,39) ¼ 3.6, p < 0.05 for rewards,
active lever and chow respectively) revealed a signiﬁcant effect of
ghrelin to increase the number of rewards earned (p < 0.0005;
Fig. 3A), the number of active lever presses (p < 0.05; Fig. 3B), and
chow intake (p < 0.05; Fig. 3C). Reward behavior-associated pa-
rameters, the rewards earned and active lever presses, were clearly
blocked by SCH-23390 pretreatment (Fig. 3A, B). Activity at the
inactive leverwasminor and did not differ signiﬁcantly between the
different treatment groups (Fig. 3B) suggesting that treatment does
not produce unspeciﬁc non-goal directed changes in activity. Chow
hyperphagia observed after ghrelin was microinjected into the VTA
was not altered by SCH-23390 pretreatment (Fig. 3C). These data
demonstrate that dopamine and D1-like receptors in the NAc shell
are downstream of ghrelin and are necessary for VTA administered
ghrelin to exert its effects on food reward behavior. They are not,
however, essential for ghrelin’s ability to increase chow intake. NAc
treatment with SCH-23390 had no effect per se on either operant
responding for food or chow intake (Fig. 3).Fig. 3. The effects of intra-NAc shell D1 receptor blockade on intra-VTA ghrelin-induced f
antagonist, SCH-23390, entirely blocked the ghrelin-induced increase in sucrose rewards ear
lever (gray bars) was not affected by any of the treatments (B). Intra-VTA ghrelin hyperpha
shown as means þ SE. n ¼ 12e14. *p < 0.05, ***p < 0.005.3.2. Effect of D2 blockade (NAc) on VTA ghrelin-induced food
reward and chow intake
To determine whether activity at the D2s is necessary for
expression of the VTA ghrelin-induced elevation of food reward
behavior, the impact of pretreatment with a selective D2 antagonist
(eticlopride hydrochloride) on ghrelin-induced increase in sucrose
operant behavior was tested. One way ANOVA demonstrated a sig-
niﬁcant effect of drug treatment (F(3,18)¼ 9.5, p< 0.0005; F(3,18)¼ 8.1,
p < 0.001; F(3,39) ¼ 3.8, p < 0.05 for rewards, active lever and chow
respectively). A post hocTukey test indicated a signiﬁcant increase in
rewards earned (p< 0.01; Fig. 4A) and active lever presses (p< 0.01;
Fig. 4B) after ghrelin treatment that were blocked with eticlopride
pretreatment. Activity at the inactive lever was minor and did not
differ signiﬁcantly between the different treatment groups (Fig. 4B).
In contrast to the operant responding data, eticlopride pretreatment
did not alter the ghrelin-induced increase in chow intake (p < 0.05;
Fig. 4C). In this combination study the interactionwas conﬁrmed by
two-way ANOVA between pretreatment  ghrelin in rewards
earned: F(1,24) ¼ 4.8, p < 0.05; active lever presses: F(1,24) ¼ 4.7,
p < 0.05 but not chow intake. Thus D2 receptors may be utilized by
ghrelin to induce changes in reward-related behaviors but not chow
consumption.
3.3. Effect of D1-like and/or D2 receptor blockade (NAc) on VTA
ghrelin-induced chow intake
To seek further validation of the lack of effect of the two dopa-
mine antagonists on chow feeding, we repeated the study, this time
in rats never exposed to the operant conditioning paradigm. This
validation study was extended to include a third test in which we
explored the effects of co-delivery of the D1-like and D2 receptor
antagonists to the NAc on VTA ghrelin-driven food intake. Chow
intake was signiﬁcantly increased by VTA ghrelin at 2 h after in-
jection (one way ANOVA: F(3,30) ¼ 6.4, p < 0.005 and F(3,27) ¼ 9.0,
p < 0.0005 for the D1 and D2 receptor study respectively) and this
was unaffected by pretreatment with either the D1-like (Fig. 5A) or
the D2 receptor antagonist (Fig. 5B). In the ﬁnal test, exploring the
combined effect of the two dopamine receptor antagonists, we
could not detect a signiﬁcant effect of VTA ghrelin until the 3 h time
point, perhaps reﬂecting the impact of the triple parenchymal in-
jection needed in this study. Oneway ANOVA indicated a signiﬁcant
effect of treatment (F(3,30) ¼ 9.6, p < 0.0005). Food intake after VTAood reward behavior and chow hyperphagia. Pretreatment with the D1-like receptor
ned (A), and number of active lever presses (black bars) while the activity at the inactive
gia was not attenuated by NAc shell selective blockade of D1 receptors (C). Values are
Fig. 4. The effects of intra-NAc shell D2 receptor blockade on intra-VTA ghrelin-induced food reward behavior and chow hyperphagia. Pretreatment with the D2 receptor
antagonist, eticlopride hydrochloride (ETC), abolished the ghrelin-induced increase in sucrose rewards earned (A), and number of active lever presses (black bars) while the activity
at the inactive lever (gray bars) was not affected by any of the treatments (B). In contrast intra-VTA ghrelin hyperphagia was not attenuated by NAc shell selective blockade of D2
receptors (C). Values are shown as means þ SE. n ¼ 7. *p < 0.05, **p < 0.01.
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ever, this was again not suppressed by co-application of the
dopamine receptor antagonists to the NAc (Fig. 5C). Note that the
combined application of both dopamine receptor antagonists to the
NAc had no effect per se on food intake.
3.4. Effect of D1-like and D2 receptor blockade on food deprivation-
induced food reward and chow intake
Food deprivation elevates both operant responding and 1 h
chow intake; rats pressed the active lever nearly twice as much
when hungry and three to six times more chow at the 1 h mea-
surement point (compare vehicle condition in Figs. 3 and 4).
Blockade of D1-like receptors in the NAc shell signiﬁcantly reduced
the food deprivation-induced elevation in food reward behavior
when assessed as a reduction in food rewards earned (p < 0.01;
Fig. 6A) and a reduction in active lever presses (p < 0.01; Fig. 6B).
This treatment did not have any signiﬁcant effects on food-
deprivation-induced chow intake (Fig. 6C). Infusion of a D2 antag-
onist into the NAc shell signiﬁcantly reduced food deprivation-
induced elevation in food reward behavior when assessed as a
reduction in food rewards earned (p < 0.01; Fig. 7A). Even though
every rat reduced its active lever pressing after D2 blockade in the
NAc the effect resulted in a trend (p ¼ 0.08; Fig. 7B) likely due to
high baseline variability in lever pressing (standard error ¼ 86 for
vehicle and 41 for drug conditions, range of active lever pressing on
vehicle from 57 to 707 presses). Removal of the highest responding
rat from the data set results in p ¼ 0.001. Notably the removed rat
showed 707 presses on vehicle and only 303 on drug, thus also
supporting the overall conclusion. Neither dopamine receptor
antagonist altered lever pressing at the inactive lever. Chow intake
was not altered by the D2 blockade in the NAc (Fig. 7C).
3.5. Food deprivation-induced changes in dopamine-related gene
expression in NAc
Overnight fasting had a signiﬁcant impact on the mRNA
expression of several dopamine related genes in the NAc. Expres-
sion of mRNA of dopamine receptor D2 was signiﬁcantly reduced
while dopamine receptor D5 mRNA was elevated. Dopamine re-
ceptor D1, D3, COMT and MAO mRNAs were not altered by the
overnight fasting (Fig. 8). D1 and D2 receptors are considered the
most abundant dopamine receptor in the brain while D3 and D5presence in CNS is a lotmore restricted. We therefore compared the
mRNA levels in the accumbens of D5 receptors to D1 and arrived at
2%; a similar relationship was detected for D3 and D2 (data not
shown). Thus here we conﬁrm that within NAc the majority of
dopamine receptor mRNA is made up of that of the D1 and D2
receptors while D3 and D5 receptors represent only a small fraction
of the total dopamine receptor mRNA detected in the NAc.4. Discussion
The major ﬁndings of the current study indicate that dopamine
signaling in the shell of the NAc is a necessary downstream medi-
ator of ghrelin’s effects on food reward. The results indicate that D1-
like and D2 receptors in the shell of NAc are key components of the
ghrelin-activated circuitry and are essential for VTA applied ghrelin
to exert its effects on food reward behavior. D1-like and D2 receptor
signaling in the NAc (shell) are not, however, essential for ghrelin’s
ability to increase chow intake. These data suggest a divergence in
the neural targets for ghrelin that control food reinforcement vs.
food intake. Finally our ﬁndings indicate that this circuitry is also
engaged by endogenous ghrelin as, in a state of hunger, when
circulating ghrelin levels are elevated, dopamine signaling in the
NAc is required for the increased food reward behavior.
Surprisingly, while it is clear that ghrelin has an impact on the
dopaminergic system (Abizaid et al., 2006; Jerlhag et al., 2007;
Kawahara et al., 2009; Weinberg et al., 2011), this is the ﬁrst study
to demonstrate that ghrelin’s effects on food reward require NAc
dopamine receptor signaling (in this case, D1-like andD2 signaling).
This emerged as an important question as other hormones or
neuropeptides linked to appetite control have recently been shown
to have a rather unexpected relationship with the mesolimbic
dopamine system. Leptin, for example, like ghrelin, has receptors on
the dopamine neurons in the VTA; most of these leptin-sensitive
dopaminergic neurons, however, do not project to the striatum
but instead innervate the amygdala (Hommel et al., 2006; Leshan
et al., 2010). Melanocortin, a potent anorexigenic neuropeptide
with receptors in the VTA, in contrast to what may be predicted for
an anorexic agent, actually increases dopaminergic activity and
dopamine release in the striatum, while clearly reducing food
intake behavior (Torre and Celis, 1988; Lindblom et al., 2001; Cone,
2005). Another layer of complexity is added by data indicating that
the dopamine- releasing effect of ghrelin appears to be dependent
on the availability of food: NAc dopamine levels detected by
Fig. 5. The effects of intra-NAc shell dopamine receptor blockade on intra-VTA ghrelin-
induced chow hyperphagia in rats without any prior operant training or sucrose
exposure. VTA ghrelin-induced hyperphagia measured at 2 h post-injection was not
suppressed by NAc pre-treatment with either (A) a D1-like receptor antagonist, SCH-
23390 (SCH) or (B) a D2 receptor antagonist, eticlopride hydrochloride (ETC). In (C),
chow hyperphagia induced by ghrelin measured at the 3 h time point was not sup-
pressed by NAc coadministration of both antagonists. Values are shown as means þ SE.
n ¼ 10e11. *p < 0.05, **p < 0.01.
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rats that were allowed to eat after ghrelin administration (as in the
experimental conditions used in the present study) and were even
suppressed by ghrelin in those that were denied access to food
(Kawahara et al., 2009), an effect recently shown to involve differ-
ential opioid signaling pathways in the VTA (Kawahara et al., 2013).
These two examples emphasize the complexity in the relationship
between feeding peptides, food availability and dopamine and
highlight the importance of studies exploring the utility of ghrelin’s
effects on the dopamine system in food reward behavior.
An interesting aspect of the results is the contrasting effect of
NAc dopamine receptor blockade on food motivation vs. food
intake. Notably, we conﬁrmed the lack of effect of suppressed NAc
dopamine signaling on VTA ghrelin-induced food intake in 2 in-
dependent studies: in one paradigm the food intake measurement
wasmade immediately after the operant responding test (for which
eating sugar rewards could have altered subsequent chow intake)
and, in the other, only food intake was measured in the animals
without prior operant testing. Additionally, in the second experi-
ment we were able to show that co-application of both dopamine
receptor antagonists to the NAc had no effect on VTA ghrelin-
induced food intake, increasing support for the hypothesis that
NAc dopamine signaling via D1-like and D2 receptors is not
required for ghrelin hyperphagia. Taken together with the fact that
the antagonists interrupt VTA ghrelin-induced food motivated
behavior, these collective results suggest a divergence of neuro-
circuitry downstream of VTA ghrelin, with one branch controlling
food intake and the other food motivation/reward. It appears that
ghrelin utilizes dopamine to alter food motivation but not intake.
Previously, we showed that VTA ghrelin engages neuropeptide Y in
the VTA selectively to control food intake and opioids in an opposite
manner (Skibicka et al., 2012a). Thus, there already exists prece-
dence for a divergence in the circuitry engaged by ghrelin for food
intake versus food-motivated behavior.
Accumbal D1-like receptors have a well-established role in both
drug and food reinforcement with an array of previous evidence
indicating that intra-NAc D1-like antagonist infusion reduces goal-
oriented behavior toward food. Systemic D1-like receptor antago-
nists reduce cue- or context-induced self-administration of cocaine,
heroin, nicotine and alcohol [for example (Weissenborn et al., 1996;
Liu and Weiss, 2002; Bossert et al., 2007; Liu et al., 2010)], high-
lighting the key role of these receptors in reward-oriented pro-
cesses. The present data indicate that NAc D1-like receptors are an
essential element of the circuitry activated by VTA-acting ghrelin.
Supportively, peripheral application of this D1 antagonist has also
been shown to reduce ghrelin-enhanced object recognition (Jacoby
and Currie, 2011). However, considering that peripheral application
targets all D1-expressing neuronal populations in the brain and
that populations outside of the NAc (for example, in the hippo-
campus) can have a major role in learning and memory, it is not
clear whether the NAc population examined here contribute to the
memory enhancing effects of ghrelin.
D2 receptors often act in concert with D1; thus many studies
indicate a role of D2 receptors in aspects of reward processing and
reward oriented behavior. However, it is noteworthy that D1 and
D2 receptors do not always act in the same way w.r.t. reward
function. In the amygdala, for example, blockade of D1 receptors
attenuates reinstatement to cue-induced cocaine seeking, while D2
antagonists can actually enhance this behavior (Berglind et al.,
2006). This functional dissociation may also have a neuroanatom-
ical contribution, as D2 receptors in NAc appear to serve a rather
opposite function to those in the hypothalamus. While in the NAc
stimulation of D2 receptors can increase food motivation, making
an animal more likely to exert effort to obtain food, in the hypo-
thalamus stimulation of D2 receptors is clearly anorexic (Leibowitz
Fig. 6. The effects of intra-NAc shell D1 receptor blockade on food deprivation-induced elevation in food reward behavior and chow hyperphagia. Pretreatment with the D1 re-
ceptor antagonist, SCH-23390, attenuated the food deprivation-induced increase in sucrose rewards earned (A), and number of active lever presses while the activity at the inactive
lever was not affected by any of the treatments (B). Chow hyperphagia was not attenuated by NAc shell selective blockade of D1 receptors (C). Values are shown as means þ SE.
n ¼ 20. **p < 0.01.
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difﬁcult to interpret results after peripheral application of D2-
targeting drugs for which the target receptor populations are
linked to opposing function. This might be one of the reasons that
explain why, in a previous study, peripheral injection of a D2
antagonist had no effect on ghrelin-induced responding for a su-
crose solution. Another possible explanation is that D2 is an
autoreceptor on the dopamine-producing neurons in the substantia
nigra and VTA, where its activation can lead to a suppression of
dopaminergic activity (Lacey et al., 1987). Thus, when injected
peripherally, D2-targeting drugs could potentially gain access to
this receptor population, while in our study only the NAc shell D2
receptor were targeted. Notably, the net effect of systemic D1-like
receptor blockade did block the responding for a sucrose drink in
the same paradigm (Overduin et al., 2012). Furthermore, systemic,
subcutaneous injection of a D1 agonist appears to enhance the
preference for palatable food while systemic injection of a D2
agonist reduces it (Cooper and Al-Naser, 2006). Thus, it seems that
our data indicating a suppressing effect of D1 antagonists on
ghrelin-induced food motivation is in line with the overall netFig. 7. The effects of intra-NAc shell D2 receptor blockade on food deprivation-induced eleva
antagonist, eticlopride hydrochloride (ETC), reduced the food deprivation-induced increas
presses (B). The activity at the inactive lever was not affected by any of the treatments (B). Ch
Values are shown as means þ SE. n ¼ 7. **p < 0.01.(suppressive) effect of stimulating D1 receptors on reward function.
By contrast, the net effect of D2 receptor population follows more
closely with that what is known about the hypothalamic D2 re-
ceptors, than the data presented here for the NAc.
In the present study both D1-like and D2 antagonists were able
to block operant behavior for sucrose after VTA ghrelin adminis-
tration and after food deprivation suggesting that a cooperative
action at both receptors in the NAc is needed for ghrelin to exert its
effects. This makes sense when considering the endogenous situ-
ation in which VTA-derived dopaminergic terminals release dopa-
mine in the NAc shell simultaneously activating all accessible
dopamine receptors. The need for simultaneous activation of both
D1-like and D2 receptors has already been reported for other be-
haviors including reinforcement (Ikemoto et al., 1997) and loco-
motor activity (Plaznik et al., 1989) as well as neuronal ﬁring
(White, 1987). The results of the present study indicate that
blockade of only one of the two dopaminergic receptors was suf-
ﬁcient to reduce those behaviors just as blockade of either one of
those receptors was sufﬁcient to reduce ghrelin-driven sucrose
operant behavior. The mechanism behind this interaction istion in food reward behavior and chow hyperphagia. Pretreatment with the D2 receptor
e in sucrose rewards earned (A), and tended to attenuate the number of active lever
ow hyperphagia was not attenuated by NAc shell selective blockade of D2 receptors (C).
Fig. 8. Nucleus accumbens dopamine signaling-related gene expression detected after
food restriction. Values are shown as means þ SE. *p < 0.05.
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ceptors. One possibility is the involvement of heterodimers is
required for the reward response, the formation of heterodimers by
the D1 and D2 receptors was reported recently and this coupling
was shown to contribute to depression-like behavior (Pei et al.,
2010). Nevertheless, our results indicate that D1 and D2 signal in
the NAc is not redundant, and each receptor is needed in order to
transmit the ghrelin effect on food reward since individual
blockade was effective in attenuating the reward response. Addi-
tionally, since individual blockade was not effective for ghrelin
hyperphagia, we have separately evaluated the possibility whether
the D1 and D2 signal was redundant for chow intake, i.e. simulta-
neous blockade of both would be needed to eliminate the response.
This, however, was not the case as ghrelin hyperphagia was not
affected by the simultaneous blockade of D1 and D2 receptors in
the NAc. Thus alone or in combination the NAc shell D1 and D2
receptor signaling is not utilized by ghrelin to increase chow intake.
Here,we targeted the D1-like andD2 receptors in the shell of the
NAc. The functionof shell and coreof theNAcseems tobedissociable
to some degree especially with the core underlying changes in drug
self-administration linked to discrete cue and the shell being more
inﬂuential in context dependent drug self-administration (Bossert
et al., 2007). This functional dissociation is supported by the
neuroanatomical connections, where the core receives more input
from the amygdala and the shell is more densely innervated by the
hippocampus (Groenewegen et al., 1999; Floresco et al., 2001). Rats
will also self-administer the combination of D1 and D2 receptor
agonists only in the shell of NAc and not in the core (Ikemoto et al.,
1997), indicating that their cooperative actionon reward is primarily
linked to the shell region targeted here.
In the present study, we explored speciﬁcally, the impact of
suppressed NAc dopamine signaling on food intake and food moti-
vated behavior driven by VTA-applied ghrelin. It should be noted,
however, that ghrelinmay also drive feeding behaviors byactivating
afferent pathways to the VTA. For example, ghrelin has been shown
to enhance food-reinforced behaviors by activating orexin neurons
in the lateral hypothalamus (Perello et al., 2010), an orexinergic cell
group that projects to the VTA and stimulate dopamine release
(Narita et al., 2006). While our study using neuroanatomy and
neuropharmacology speciﬁcally dissects the VTA-NAc pathway, in
an endogenous situation ghrelin released in the circulation likely
stimulates the VTA as wells as other brain nuclei expressing ghrelin
receptor with efferent projections to the VTA. Thus, in a physiolog-
ical situation, the impact of ghrelin is distributed over many sites in
the brain which likely act in concert. The concept of a hormone or a
neuropeptide acting on many distributed sites in the brain from
which it can elicit a similar outcome, for example a change in food
intake, is notnovel andhas alreadybeingproposedandevaluated forleptin and melanocortin (Grill, 2006; Leinninger et al., 2009;
Skibicka and Grill, 2009; Faulconbridge and Hayes, 2011).
Food deprivation is associated with high levels of circulating
ghrelin. In conditions of food deprivation food presentation elicits a
dopamine release in the NAc (Kawahara et al., 2013). It follows that
nutritional state, may also inﬂuence dopamine signaling in the NAc,
the impact of food deprivation on mRNA expression of dopamine
receptors (D1-like receptors (D1, D5) andD2-like receptors (D2,D3))
and dopamine degrading enzymes (MAO, COMT) evaluated in the
present study. While food deprivation did not alter the mRNA
expression of any of the dopamine degrading enzymes measured,
we did see a differential regulation of D5 vs. D2 receptors. The
expression ofD5 receptorswas increasedbynearly 30%while theD2
receptor mRNA was reduced by about 20%. Consistent with this
divergence, simultaneous application of D1-like and D2 receptor
agonists has been previously shown to down-regulate D2 receptors
but to upregulate D1 receptors in the substantia nigra (and with a
similar trend in the NAc) (Subramaniam et al., 1992). Interestingly,
the effects of fooddeprivationonNAcdopamine receptor expression
converge with our data demonstrating a role for D1-like (that
includeD5) andD2 receptors in fasting-inducedmotivation for food.
One caveat of our study is that food deprivation increases
circulating ghrelin levels so that other ghrelin receptors populations
outside of the VTA can potentially be activated. Thus, while food
deprivation is an endogenous and more physiologically relevant
way to increase ghrelin, it does not allow for selective VTA stimu-
lation. We cannot therefore eliminate the possibility that the
dopamine receptor changes detected in the NAc are a result of
ghrelin activity in areas outside of theVTAwith an indirect inﬂuence
on the NAc. Finally, it should be noted that our data link fasting to
changes in NAc dopamine receptor expression but further experi-
ments would be required to show mediation of the (ghrelin-stim-
ulated) VTA-NAc dopaminergic projection in this effect and, indeed,
to explore the role of other pathways and transmitter systems in this
effect, like the lateral hypothalamus (as discussed above).
Sincemanyof theneurobiological substrates are common toboth
drug addiction and disordered eating, it is possible that present
ﬁndings are indicative of a role of D1-like and D2 receptors in drug
and alcohol reinforcing effects of ghrelin (Dickson et al., 2011). Both
food and cocaine reward lead to a release of dopamine in the NAc
(Hernandez and Hoebel, 1988). Blockade of D1 or D2 receptors re-
duces rewardbehavior fordrugs of abuse, alcohol andnicotine. Since
a considerable contribution of ghrelin to intake or reward behavior
for all these substances has been reported previously, it is rather
likely that the ghrelin-VTA-dopamine-NAc circuitry described here
is relevant for an array of reward behaviors and not exclusively for
food. Preliminary support for this idea can be drawn from data
demonstrating that food deprivation can reinstate heroin seeking
that is blocked by blockade of D1-like receptors (Tobin et al., 2009).
Our data provide new knowledge about an integration of two
key food reward-linked signaling systems: the VTA-driven circuits
that are responsive to the orexigenic hormone, ghrelin, and the NAc
dopamine-responsive circuits. In particular we show that ghrelin’s
well-documented VTA-linked effects on food-motivated behavior
require D1 and D2 signaling in the NAc. Our data also indicate that
the VTA-driven (D1/D2-dependent) effects of ghrelin on food
reward involve divergent circuitry to those important for food
intake, as neither antagonist affected ghrelin-induced food intake
when delivered to the NAc. Finally, studies in hungry (overnight
fasted and hence, hyperghrelinemic) rats implicate NAc D1/D2
signaling in the effects of endogenous ghrelin on food-motivated
behavior. Thus, mechanisms and therapies interfering with dopa-
mine signaling in the NAc appear to have relevance for ghrelin-
mediated effects on the reward system, including those linked to
feeding control and hence, obesity and its treatment.
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